IVC Evidensia UK andamp; IE Revenue and Competitors

Bristol,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • IVC Evidensia UK andamp; IE's estimated annual revenue is currently $70.9M per year.(i)
  • IVC Evidensia UK andamp; IE's estimated revenue per employee is $175,000

Employee Data

  • IVC Evidensia UK andamp; IE has 405 Employees.(i)
  • IVC Evidensia UK andamp; IE grew their employee count by 25% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$14.1M1015%N/AN/A
#2
$1.6M19-71%N/AN/A
#3
$212.8M10635%$65MN/A
#4
$6.8M548%N/AN/A
#5
$12.9M922%$23.1MN/A
#6
$1M12N/AN/AN/A
#7
$106.5M599-17%$2.3MN/A
#8
$35.6M2316%N/AN/A
#9
$38.3M2495%N/AN/A
#10
$45M299-4%$102.6MN/A
Add Company

What Is IVC Evidensia UK andamp; IE?

IVC Evidensia is a leading veterinary services provider with a network of more than 1,300 clinics and hospitals and approximately 16,000 employees across 10 countries in Europe. Core to our mission are clinical independence, international cooperation, and continuous education to develop our people and their careers. As a Disability Confident Employer we are keen to hear from candidates with disabilities and long term health conditions, and would be happy to discuss any reasonable adjustments needed during the recruitment process.

keywords:N/A

N/A

Total Funding

405

Number of Employees

$70.9M

Revenue (est)

25%

Employee Growth %

N/A

Valuation

N/A

Accelerator

IVC Evidensia UK andamp; IE News

2022-04-17 - Vet school hockey team stands out from the herd with new ...

IVC Evidensia division sponsors the University of Bristol vet school's hockey team, providing cow print hockey shirts for the players.

2022-04-13 - Boston Spa vets give aid to children’s hospice and pool charity

... Boston Spa and Wetherby, got together to apply for a community grant, made available from the practice's parent company, IVC Evidensia.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$71.1M406-28%N/A
#2
$52.3M4102%N/A
#3
$94.7M42110%N/A
#4
$130.4M4248%N/A
#5
$35M4289%N/A